Asymmetric Dimethylarginine, Plasma
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
An adjunct to other risk markers for assessing an individualâ€™s overall probabilistic likelihood of future coronary events, especially in patients with renal failure.
This test is best used to aid in eliciting lifestyle changes that can reduce risk of coronary events; it does not predict absolute events, nor does it predict specific events.
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Asymmetric Dimethyl Arginine, P
Asym dime arginine